@article{d216ac20ab5440269152f0ca726f8b7e,
title = "Alemtuzumab and treatment of chronic lymphocytic leukemia and its immune-related disorders: one player on two tables",
abstract = "NA",
keywords = "Antibodies, Monoclonal, Humanized, Guillain-Barre Syndrome, Humans, Leukemia, Lymphocytic, Chronic, B-Cell, Male, Antibodies, Monoclonal, Humanized, Guillain-Barre Syndrome, Humans, Leukemia, Lymphocytic, Chronic, B-Cell, Male",
author = "Luca Laurenti and Giovanni D'Arena",
year = "2014",
doi = "10.1159/000359949",
language = "English",
volume = "132",
pages = "237--239",
journal = "Acta Haematologica",
issn = "0001-5792",
publisher = "S Karger AG:Allschwilerstrasse 10, CH-4009 Basel Switzerland:011 41 61 3061111, EMAIL: orders@karger.ch, INTERNET: http://www.karger.com, Fax: 011 41 61 3061234",
}